Biotech Growth N V

10% Owner

1 company

Average

Trades Analyzed

12M Win Rate

25.0%

Avg 3M Return

+20.6%

Avg 12M Return

-14.6%

Biotech Growth N V is a 10% Owner at Black Diamond Therapeutics, Inc.. Recent SEC Form 4 filings include 13 buys and 7 sells.

Estimated insider holdings value: $8.2M based on current market prices.

Holdings by Company

BDTXMar 19, 2025

Current Shares2.73M

Value$8.17M

Net Activity-1,002,299

Bought: 4.78MSold: 5.78M

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 19, 2025	BDTX Black Diamond Therapeutics, Inc.	10% Owner	Sell	5,784,292	$2.07	$11,997,749.13	-14.2%	+34.9%	+25.0%
Oct 17, 2023	BDTX Black Diamond Therapeutics, Inc.	10% Owner	Buy	400,000	$2.34	$934,080.00	+4.9%	+20.5%	+45.3%
Jun 30, 2023	BDTX Black Diamond Therapeutics, Inc.	10% Owner	Buy	1,000,000	$5.00	$5,000,000.00	+14.0%	-41.4%	-7.7%
Jun 27, 2023	BDTX Black Diamond Therapeutics, Inc.	10% Owner	Buy	1,740,000	$5.49	$9,555,036.00	+32.4%	-48.7%	-24.1%
Oct 31, 2022	BDTX Black Diamond Therapeutics, Inc.	10% Owner	Buy	99,801	$2.25	$224,911.53	+1.9%	+30.3%	-18.6%
Oct 28, 2022	BDTX Black Diamond Therapeutics, Inc.	10% Owner	Buy	364,652	$2.02	$736,185.98	+3.6%	+35.3%	-19.9%
Oct 21, 2022	BDTX Black Diamond Therapeutics, Inc.	10% Owner	Buy	87,850	$1.51	$132,750.14	+1.8%	+93.0%	+32.9%
Oct 20, 2022	BDTX Black Diamond Therapeutics, Inc.	10% Owner	Buy	131,423	$1.36	$179,120.05	+1.4%	+115.1%	+43.8%
Apr 28, 2022	BDTX Black Diamond Therapeutics, Inc.	10% Owner	Buy	405,711	$2.61	$1,057,347.69	+4.6%	+33.5%	-45.6%
Apr 19, 2022	BDTX Black Diamond Therapeutics, Inc.	10% Owner	Buy	300,000	$3.27	$980,580.00	+3.7%	-5.2%	-51.2%